Exposure history impacts universal flu vax development, research says; Medigene touts early AML data;

> A new study suggests that immune system history could play a big role in scientists' ability to create a universal flu vaccine. Report

> Medigene unveiled "promising" early data from ongoing dendritic cell vaccine trials in patients with acute myeloid leukemia. Release

> The development of a new vaccine is one objective of a recently announced strategy to defeat tuberculosis as a public health threat by 2035. Report

> A University of Helsinki study demonstrated the potential for scientists to predict influenza evolution and create better seasonal vaccines by using genomic information from virus strains in circulation. Report

> Ann Arbor, MI-based NanoBio said its intranasal nanoemulsion adjuvanted chlamydia vaccine demonstrated efficacy in a mouse challenge. Release

And Finally... Science Friday examined the etymology of the word "vaccine." More

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.